Abstract
Rowell Park Cancer Institute
Officials at OmniSeq say they have begun commercializing a suite of products that support a physician-driven, collaborative approach to genomic diagnostics, i.e., matching cancer patients to therapies tailored specifically to them. The company, which recently spun out from the Roswell Park Cancer Institute in Buffalo, focuses on its OmniSeqSM Precision Medical Technology.
The methodology provides oncology groups, hospitals, and healthcare systems with a “fusion of clinical genomics and a comprehensive information technology solution that provides easy access to actionable insights about their patient's condition and available treatment options,” according to Carl Morrison, M.D., D.V.M., president, CSO, and company founder.
Dr. Morrison explains that the company's platform gives physicians the tools required to obtain comprehensive information about a patient's cancer through a proprietary, clinically actionable, genomic sequencing algorithm and a system that continuously ingests and analyzes peer-generated clinical experiences and therapeutic outcomes for patients. “This allows oncologists to break through the noise and immediately focus on the solution,” adds Dr. Morrison.
OmniSeq Precision Medical Technology consists of three components. OmniSeq TargetSM is a differentiated cancer diagnostic that leverages dual next-generation sequencing and a proprietary algorithm designed to resolve inconsistencies in solid tumor identification. OmniSeq ConnectSM, a paperless, web-based, end-to-end IT solution, reportedly removes the hurdles that have traditionally stood between physicians and actionable genomic information. OmniSeq Connect gives physicians complete control with rapid results that are directly connected into a patient's electronic medical records, notes Dr. Morrison.
He explains that OmniSeq Genomic NetworkSM serves as an interconnected, resource-sharing, physician-led collaboration that provides physicians and their teams with actionable cancer information and the practical expertise to put it into use.